Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, CB #7080, Chapel Hill, NC 27599, USA.
Cleve Clin J Med. 2011 Jan;78(1):39-49. doi: 10.3949/ccjm.77a.10087.
Proton pump inhibitors (PPIs) are widely prescribed for acid-peptic disease. In general, the safety of this class of drugs has been excellent. However, in the past several years, epidemiologic studies have indicated possible risks that are biologically plausible.
质子泵抑制剂(PPIs)广泛用于治疗酸相关疾病。总的来说,该类药物的安全性非常好。然而,在过去几年中,流行病学研究表明其存在一些生物学上合理的潜在风险。